 | • レポートコード：MRC2-11QY02285 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はαグルコシダーゼ阻害剤のグローバル市場について調査・分析したレポートです。種類別（ダンピング症候群、2型糖尿病）市場規模、用途別（オンライン薬局、小売薬局、病院薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別αグルコシダーゼ阻害剤の競争状況、市場シェア ・世界のαグルコシダーゼ阻害剤市場：種類別市場規模 2015年-2020年（ダンピング症候群、2型糖尿病） ・世界のαグルコシダーゼ阻害剤市場：種類別市場規模予測 2021年-2026年（ダンピング症候群、2型糖尿病） ・世界のαグルコシダーゼ阻害剤市場：用途別市場規模 2015年-2020年（オンライン薬局、小売薬局、病院薬局） ・世界のαグルコシダーゼ阻害剤市場：用途別市場規模予測 2021年-2026年（オンライン薬局、小売薬局、病院薬局） ・北米のαグルコシダーゼ阻害剤市場分析：米国、カナダ ・ヨーロッパのαグルコシダーゼ阻害剤市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのαグルコシダーゼ阻害剤市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のαグルコシダーゼ阻害剤市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのαグルコシダーゼ阻害剤市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Bayer pharma、Takeda、Sun pharma、Glenmark pharma、Torrent、Hexalag、Unichem ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Alpha-glucosidase is an enzyme that is inhibited by alpha-glucosidase inhibitor drugs. Alpha-glucosidase helps in absorption of carbohydrates by breaking down carbohydrates into tiny sugar molecules such as glucose. The inhibition is reversible, and competitive inhibition. Alpha-glucosidase inhibitor drugs help in delaying glucose absorption and slow the digestion of carbohydrates. This results in lower rise of glucose in the blood after meals and remains effective throughout the day.
Acarbose is the most widely prescribed of the three currently available (Acarbose, Miglitol, and Voglibose) alpha‐glucosidase inhibitors and has been used in the management of hyperglycemia for years.
Market Analysis and Insights: Global Alpha Glucosidase Inhibitors Market
The global Alpha Glucosidase Inhibitors market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Alpha Glucosidase Inhibitors Scope and Market Size
Alpha Glucosidase Inhibitors market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Alpha Glucosidase Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Alpha Glucosidase Inhibitors market is segmented into
Dumping Syndrome
Type 2 Diabetes
Segment by Application, the Alpha Glucosidase Inhibitors market is segmented into
Online Pharmacies
Retail Pharmacies
Hospital Pharmacies
Regional and Country-level Analysis
The Alpha Glucosidase Inhibitors market is analysed and market size information is provided by regions (countries).
The key regions covered in the Alpha Glucosidase Inhibitors market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Alpha Glucosidase Inhibitors Market Share Analysis
Alpha Glucosidase Inhibitors market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Alpha Glucosidase Inhibitors business, the date to enter into the Alpha Glucosidase Inhibitors market, Alpha Glucosidase Inhibitors product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Bayer pharma
Takeda
Sun pharma
Glenmark pharma
Torrent
Hexalag
Unichem
1 Study Coverage
1.1 Alpha Glucosidase Inhibitors Product Introduction
1.2 Market Segments
1.3 Key Alpha Glucosidase Inhibitors Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Alpha Glucosidase Inhibitors Market Size Growth Rate by Type
1.4.2 Dumping Syndrome
1.4.3 Type 2 Diabetes
1.5 Market by Application
1.5.1 Global Alpha Glucosidase Inhibitors Market Size Growth Rate by Application
1.5.2 Online Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Hospital Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Alpha Glucosidase Inhibitors Market Size, Estimates and Forecasts
2.1.1 Global Alpha Glucosidase Inhibitors Revenue 2015-2026
2.1.2 Global Alpha Glucosidase Inhibitors Sales 2015-2026
2.2 Global Alpha Glucosidase Inhibitors, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Alpha Glucosidase Inhibitors Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Alpha Glucosidase Inhibitors Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Alpha Glucosidase Inhibitors Competitor Landscape by Players
3.1 Alpha Glucosidase Inhibitors Sales by Manufacturers
3.1.1 Alpha Glucosidase Inhibitors Sales by Manufacturers (2015-2020)
3.1.2 Alpha Glucosidase Inhibitors Sales Market Share by Manufacturers (2015-2020)
3.2 Alpha Glucosidase Inhibitors Revenue by Manufacturers
3.2.1 Alpha Glucosidase Inhibitors Revenue by Manufacturers (2015-2020)
3.2.2 Alpha Glucosidase Inhibitors Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Alpha Glucosidase Inhibitors Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Alpha Glucosidase Inhibitors Revenue in 2019
3.2.5 Global Alpha Glucosidase Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Alpha Glucosidase Inhibitors Price by Manufacturers
3.4 Alpha Glucosidase Inhibitors Manufacturing Base Distribution, Product Types
3.4.1 Alpha Glucosidase Inhibitors Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Alpha Glucosidase Inhibitors Product Type
3.4.3 Date of International Manufacturers Enter into Alpha Glucosidase Inhibitors Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Alpha Glucosidase Inhibitors Market Size by Type (2015-2020)
4.1.1 Global Alpha Glucosidase Inhibitors Sales by Type (2015-2020)
4.1.2 Global Alpha Glucosidase Inhibitors Revenue by Type (2015-2020)
4.1.3 Alpha Glucosidase Inhibitors Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Alpha Glucosidase Inhibitors Market Size Forecast by Type (2021-2026)
4.2.1 Global Alpha Glucosidase Inhibitors Sales Forecast by Type (2021-2026)
4.2.2 Global Alpha Glucosidase Inhibitors Revenue Forecast by Type (2021-2026)
4.2.3 Alpha Glucosidase Inhibitors Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Alpha Glucosidase Inhibitors Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Alpha Glucosidase Inhibitors Market Size by Application (2015-2020)
5.1.1 Global Alpha Glucosidase Inhibitors Sales by Application (2015-2020)
5.1.2 Global Alpha Glucosidase Inhibitors Revenue by Application (2015-2020)
5.1.3 Alpha Glucosidase Inhibitors Price by Application (2015-2020)
5.2 Alpha Glucosidase Inhibitors Market Size Forecast by Application (2021-2026)
5.2.1 Global Alpha Glucosidase Inhibitors Sales Forecast by Application (2021-2026)
5.2.2 Global Alpha Glucosidase Inhibitors Revenue Forecast by Application (2021-2026)
5.2.3 Global Alpha Glucosidase Inhibitors Price Forecast by Application (2021-2026)
6 North America
6.1 North America Alpha Glucosidase Inhibitors by Country
6.1.1 North America Alpha Glucosidase Inhibitors Sales by Country
6.1.2 North America Alpha Glucosidase Inhibitors Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Alpha Glucosidase Inhibitors Market Facts & Figures by Type
6.3 North America Alpha Glucosidase Inhibitors Market Facts & Figures by Application
7 Europe
7.1 Europe Alpha Glucosidase Inhibitors by Country
7.1.1 Europe Alpha Glucosidase Inhibitors Sales by Country
7.1.2 Europe Alpha Glucosidase Inhibitors Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Alpha Glucosidase Inhibitors Market Facts & Figures by Type
7.3 Europe Alpha Glucosidase Inhibitors Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Alpha Glucosidase Inhibitors by Region
8.1.1 Asia Pacific Alpha Glucosidase Inhibitors Sales by Region
8.1.2 Asia Pacific Alpha Glucosidase Inhibitors Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Alpha Glucosidase Inhibitors Market Facts & Figures by Type
8.3 Asia Pacific Alpha Glucosidase Inhibitors Market Facts & Figures by Application
9 Latin America
9.1 Latin America Alpha Glucosidase Inhibitors by Country
9.1.1 Latin America Alpha Glucosidase Inhibitors Sales by Country
9.1.2 Latin America Alpha Glucosidase Inhibitors Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Alpha Glucosidase Inhibitors Market Facts & Figures by Type
9.3 Central & South America Alpha Glucosidase Inhibitors Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Alpha Glucosidase Inhibitors by Country
10.1.1 Middle East and Africa Alpha Glucosidase Inhibitors Sales by Country
10.1.2 Middle East and Africa Alpha Glucosidase Inhibitors Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Alpha Glucosidase Inhibitors Market Facts & Figures by Type
10.3 Middle East and Africa Alpha Glucosidase Inhibitors Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Alpha Glucosidase Inhibitors Products Offered
11.1.5 Pfizer Related Developments
11.2 Bayer pharma
11.2.1 Bayer pharma Corporation Information
11.2.2 Bayer pharma Description and Business Overview
11.2.3 Bayer pharma Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bayer pharma Alpha Glucosidase Inhibitors Products Offered
11.2.5 Bayer pharma Related Developments
11.3 Takeda
11.3.1 Takeda Corporation Information
11.3.2 Takeda Description and Business Overview
11.3.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Takeda Alpha Glucosidase Inhibitors Products Offered
11.3.5 Takeda Related Developments
11.4 Sun pharma
11.4.1 Sun pharma Corporation Information
11.4.2 Sun pharma Description and Business Overview
11.4.3 Sun pharma Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sun pharma Alpha Glucosidase Inhibitors Products Offered
11.4.5 Sun pharma Related Developments
11.5 Glenmark pharma
11.5.1 Glenmark pharma Corporation Information
11.5.2 Glenmark pharma Description and Business Overview
11.5.3 Glenmark pharma Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Glenmark pharma Alpha Glucosidase Inhibitors Products Offered
11.5.5 Glenmark pharma Related Developments
11.6 Torrent
11.6.1 Torrent Corporation Information
11.6.2 Torrent Description and Business Overview
11.6.3 Torrent Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Torrent Alpha Glucosidase Inhibitors Products Offered
11.6.5 Torrent Related Developments
11.7 Hexalag
11.7.1 Hexalag Corporation Information
11.7.2 Hexalag Description and Business Overview
11.7.3 Hexalag Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Hexalag Alpha Glucosidase Inhibitors Products Offered
11.7.5 Hexalag Related Developments
11.8 Unichem
11.8.1 Unichem Corporation Information
11.8.2 Unichem Description and Business Overview
11.8.3 Unichem Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Unichem Alpha Glucosidase Inhibitors Products Offered
11.8.5 Unichem Related Developments
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Alpha Glucosidase Inhibitors Products Offered
11.1.5 Pfizer Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Alpha Glucosidase Inhibitors Market Estimates and Projections by Region
12.1.1 Global Alpha Glucosidase Inhibitors Sales Forecast by Regions 2021-2026
12.1.2 Global Alpha Glucosidase Inhibitors Revenue Forecast by Regions 2021-2026
12.2 North America Alpha Glucosidase Inhibitors Market Size Forecast (2021-2026)
12.2.1 North America: Alpha Glucosidase Inhibitors Sales Forecast (2021-2026)
12.2.2 North America: Alpha Glucosidase Inhibitors Revenue Forecast (2021-2026)
12.2.3 North America: Alpha Glucosidase Inhibitors Market Size Forecast by Country (2021-2026)
12.3 Europe Alpha Glucosidase Inhibitors Market Size Forecast (2021-2026)
12.3.1 Europe: Alpha Glucosidase Inhibitors Sales Forecast (2021-2026)
12.3.2 Europe: Alpha Glucosidase Inhibitors Revenue Forecast (2021-2026)
12.3.3 Europe: Alpha Glucosidase Inhibitors Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Alpha Glucosidase Inhibitors Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Alpha Glucosidase Inhibitors Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Alpha Glucosidase Inhibitors Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Alpha Glucosidase Inhibitors Market Size Forecast by Region (2021-2026)
12.5 Latin America Alpha Glucosidase Inhibitors Market Size Forecast (2021-2026)
12.5.1 Latin America: Alpha Glucosidase Inhibitors Sales Forecast (2021-2026)
12.5.2 Latin America: Alpha Glucosidase Inhibitors Revenue Forecast (2021-2026)
12.5.3 Latin America: Alpha Glucosidase Inhibitors Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Alpha Glucosidase Inhibitors Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Alpha Glucosidase Inhibitors Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Alpha Glucosidase Inhibitors Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Alpha Glucosidase Inhibitors Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Alpha Glucosidase Inhibitors Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Alpha Glucosidase Inhibitors Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Alpha Glucosidase Inhibitors Market Segments
Table 2. Ranking of Global Top Alpha Glucosidase Inhibitors Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Alpha Glucosidase Inhibitors Market Size Growth Rate by Type 2020-2026 (g) & (US$ Million)
Table 4. Major Manufacturers of Dumping Syndrome
Table 5. Major Manufacturers of Type 2 Diabetes
Table 6. Global Alpha Glucosidase Inhibitors Market Size Growth Rate by Application 2020-2026 (g)
Table 7. Global Alpha Glucosidase Inhibitors Market Size by Region (g) & (US$ Million): 2020 VS 2026
Table 8. Global Alpha Glucosidase Inhibitors Sales by Regions 2015-2020 (g)
Table 9. Global Alpha Glucosidase Inhibitors Sales Market Share by Regions (2015-2020)
Table 10. Global Alpha Glucosidase Inhibitors Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Alpha Glucosidase Inhibitors Sales by Manufacturers (2015-2020) (g)
Table 12. Global Alpha Glucosidase Inhibitors Sales Share by Manufacturers (2015-2020)
Table 13. Global Alpha Glucosidase Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Alpha Glucosidase Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alpha Glucosidase Inhibitors as of 2019)
Table 15. Alpha Glucosidase Inhibitors Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Alpha Glucosidase Inhibitors Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Alpha Glucosidase Inhibitors Price (2015-2020) (USD/mg)
Table 18. Alpha Glucosidase Inhibitors Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Alpha Glucosidase Inhibitors Product Type
Table 20. Date of International Manufacturers Enter into Alpha Glucosidase Inhibitors Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Alpha Glucosidase Inhibitors Sales by Type (2015-2020) (g)
Table 23. Global Alpha Glucosidase Inhibitors Sales Share by Type (2015-2020)
Table 24. Global Alpha Glucosidase Inhibitors Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Alpha Glucosidase Inhibitors Revenue Share by Type (2015-2020)
Table 26. Alpha Glucosidase Inhibitors Average Selling Price (ASP) by Type 2015-2020 (USD/mg)
Table 27. Global Alpha Glucosidase Inhibitors Sales by Application (2015-2020) (g)
Table 28. Global Alpha Glucosidase Inhibitors Sales Share by Application (2015-2020)
Table 29. North America Alpha Glucosidase Inhibitors Sales by Country (2015-2020) (g)
Table 30. North America Alpha Glucosidase Inhibitors Sales Market Share by Country (2015-2020)
Table 31. North America Alpha Glucosidase Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Alpha Glucosidase Inhibitors Revenue Market Share by Country (2015-2020)
Table 33. North America Alpha Glucosidase Inhibitors Sales by Type (2015-2020) (g)
Table 34. North America Alpha Glucosidase Inhibitors Sales Market Share by Type (2015-2020)
Table 35. North America Alpha Glucosidase Inhibitors Sales by Application (2015-2020) (g)
Table 36. North America Alpha Glucosidase Inhibitors Sales Market Share by Application (2015-2020)
Table 37. Europe Alpha Glucosidase Inhibitors Sales by Country (2015-2020) (g)
Table 38. Europe Alpha Glucosidase Inhibitors Sales Market Share by Country (2015-2020)
Table 39. Europe Alpha Glucosidase Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Alpha Glucosidase Inhibitors Revenue Market Share by Country (2015-2020)
Table 41. Europe Alpha Glucosidase Inhibitors Sales by Type (2015-2020) (g)
Table 42. Europe Alpha Glucosidase Inhibitors Sales Market Share by Type (2015-2020)
Table 43. Europe Alpha Glucosidase Inhibitors Sales by Application (2015-2020) (g)
Table 44. Europe Alpha Glucosidase Inhibitors Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Alpha Glucosidase Inhibitors Sales by Region (2015-2020) (g)
Table 46. Asia Pacific Alpha Glucosidase Inhibitors Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Alpha Glucosidase Inhibitors Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Alpha Glucosidase Inhibitors Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Alpha Glucosidase Inhibitors Sales by Type (2015-2020) (g)
Table 50. Asia Pacific Alpha Glucosidase Inhibitors Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Alpha Glucosidase Inhibitors Sales by Application (2015-2020) (g)
Table 52. Asia Pacific Alpha Glucosidase Inhibitors Sales Market Share by Application (2015-2020)
Table 53. Latin America Alpha Glucosidase Inhibitors Sales by Country (2015-2020) (g)
Table 54. Latin America Alpha Glucosidase Inhibitors Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Alpha Glucosidase Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Alpha Glucosidase Inhibitors Revenue Market Share by Country (2015-2020)
Table 57. Latin America Alpha Glucosidase Inhibitors Sales by Type (2015-2020) (g)
Table 58. Latin America Alpha Glucosidase Inhibitors Sales Market Share by Type (2015-2020)
Table 59. Latin America Alpha Glucosidase Inhibitors Sales by Application (2015-2020) (g)
Table 60. Latin America Alpha Glucosidase Inhibitors Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Alpha Glucosidase Inhibitors Sales by Country (2015-2020) (g)
Table 62. Middle East and Africa Alpha Glucosidase Inhibitors Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Alpha Glucosidase Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Alpha Glucosidase Inhibitors Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Alpha Glucosidase Inhibitors Sales by Type (2015-2020) (g)
Table 66. Middle East and Africa Alpha Glucosidase Inhibitors Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Alpha Glucosidase Inhibitors Sales by Application (2015-2020) (g)
Table 68. Middle East and Africa Alpha Glucosidase Inhibitors Sales Market Share by Application (2015-2020)
Table 69. Pfizer Corporation Information
Table 70. Pfizer Description and Major Businesses
Table 71. Pfizer Alpha Glucosidase Inhibitors Production (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 72. Pfizer Product
Table 73. Pfizer Recent Development
Table 74. Bayer pharma Corporation Information
Table 75. Bayer pharma Description and Major Businesses
Table 76. Bayer pharma Alpha Glucosidase Inhibitors Production (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 77. Bayer pharma Product
Table 78. Bayer pharma Recent Development
Table 79. Takeda Corporation Information
Table 80. Takeda Description and Major Businesses
Table 81. Takeda Alpha Glucosidase Inhibitors Production (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 82. Takeda Product
Table 83. Takeda Recent Development
Table 84. Sun pharma Corporation Information
Table 85. Sun pharma Description and Major Businesses
Table 86. Sun pharma Alpha Glucosidase Inhibitors Production (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 87. Sun pharma Product
Table 88. Sun pharma Recent Development
Table 89. Glenmark pharma Corporation Information
Table 90. Glenmark pharma Description and Major Businesses
Table 91. Glenmark pharma Alpha Glucosidase Inhibitors Production (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 92. Glenmark pharma Product
Table 93. Glenmark pharma Recent Development
Table 94. Torrent Corporation Information
Table 95. Torrent Description and Major Businesses
Table 96. Torrent Alpha Glucosidase Inhibitors Production (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 97. Torrent Product
Table 98. Torrent Recent Development
Table 99. Hexalag Corporation Information
Table 100. Hexalag Description and Major Businesses
Table 101. Hexalag Alpha Glucosidase Inhibitors Production (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 102. Hexalag Product
Table 103. Hexalag Recent Development
Table 104. Unichem Corporation Information
Table 105. Unichem Description and Major Businesses
Table 106. Unichem Alpha Glucosidase Inhibitors Production (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 107. Unichem Product
Table 108. Unichem Recent Development
Table 109. Global Alpha Glucosidase Inhibitors Sales Forecast by Regions (2021-2026) (g)
Table 110. Global Alpha Glucosidase Inhibitors Sales Market Share Forecast by Regions (2021-2026)
Table 111. Global Alpha Glucosidase Inhibitors Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 112. Global Alpha Glucosidase Inhibitors Revenue Market Share Forecast by Regions (2021-2026)
Table 113. North America: Alpha Glucosidase Inhibitors Sales Forecast by Country (2021-2026) (g)
Table 114. North America: Alpha Glucosidase Inhibitors Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Europe: Alpha Glucosidase Inhibitors Sales Forecast by Country (2021-2026) (g)
Table 116. Europe: Alpha Glucosidase Inhibitors Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Asia Pacific: Alpha Glucosidase Inhibitors Sales Forecast by Region (2021-2026) (g)
Table 118. Asia Pacific: Alpha Glucosidase Inhibitors Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Latin America: Alpha Glucosidase Inhibitors Sales Forecast by Country (2021-2026) (g)
Table 120. Latin America: Alpha Glucosidase Inhibitors Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Middle East and Africa: Alpha Glucosidase Inhibitors Sales Forecast by Country (2021-2026) (g)
Table 122. Middle East and Africa: Alpha Glucosidase Inhibitors Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 124. Key Challenges
Table 125. Market Risks
Table 126. Main Points Interviewed from Key Alpha Glucosidase Inhibitors Players
Table 127. Alpha Glucosidase Inhibitors Customers List
Table 128. Alpha Glucosidase Inhibitors Distributors List
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Alpha Glucosidase Inhibitors Product Picture
Figure 2. Global Alpha Glucosidase Inhibitors Sales Market Share by Type in 2020 & 2026
Figure 3. Dumping Syndrome Product Picture
Figure 4. Type 2 Diabetes Product Picture
Figure 5. Global Alpha Glucosidase Inhibitors Sales Market Share by Application in 2020 & 2026
Figure 6. Online Pharmacies
Figure 7. Retail Pharmacies
Figure 8. Hospital Pharmacies
Figure 9. Alpha Glucosidase Inhibitors Report Years Considered
Figure 10. Global Alpha Glucosidase Inhibitors Market Size 2015-2026 (US$ Million)
Figure 11. Global Alpha Glucosidase Inhibitors Sales 2015-2026 (g)
Figure 12. Global Alpha Glucosidase Inhibitors Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Alpha Glucosidase Inhibitors Sales Market Share by Region (2015-2020)
Figure 14. Global Alpha Glucosidase Inhibitors Sales Market Share by Region in 2019
Figure 15. Global Alpha Glucosidase Inhibitors Revenue Market Share by Region (2015-2020)
Figure 16. Global Alpha Glucosidase Inhibitors Revenue Market Share by Region in 2019
Figure 17. Global Alpha Glucosidase Inhibitors Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Alpha Glucosidase Inhibitors Revenue in 2019
Figure 19. Alpha Glucosidase Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Alpha Glucosidase Inhibitors Sales Market Share by Type (2015-2020)
Figure 21. Global Alpha Glucosidase Inhibitors Sales Market Share by Type in 2019
Figure 22. Global Alpha Glucosidase Inhibitors Revenue Market Share by Type (2015-2020)
Figure 23. Global Alpha Glucosidase Inhibitors Revenue Market Share by Type in 2019
Figure 24. Global Alpha Glucosidase Inhibitors Market Share by Price Range (2015-2020)
Figure 25. Global Alpha Glucosidase Inhibitors Sales Market Share by Application (2015-2020)
Figure 26. Global Alpha Glucosidase Inhibitors Sales Market Share by Application in 2019
Figure 27. Global Alpha Glucosidase Inhibitors Revenue Market Share by Application (2015-2020)
Figure 28. Global Alpha Glucosidase Inhibitors Revenue Market Share by Application in 2019
Figure 29. North America Alpha Glucosidase Inhibitors Sales Growth Rate 2015-2020 (g)
Figure 30. North America Alpha Glucosidase Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Alpha Glucosidase Inhibitors Sales Market Share by Country in 2019
Figure 32. North America Alpha Glucosidase Inhibitors Revenue Market Share by Country in 2019
Figure 33. U.S. Alpha Glucosidase Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 34. U.S. Alpha Glucosidase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Alpha Glucosidase Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 36. Canada Alpha Glucosidase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Alpha Glucosidase Inhibitors Market Share by Type in 2019
Figure 38. North America Alpha Glucosidase Inhibitors Market Share by Application in 2019
Figure 39. Europe Alpha Glucosidase Inhibitors Sales Growth Rate 2015-2020 (g)
Figure 40. Europe Alpha Glucosidase Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Alpha Glucosidase Inhibitors Sales Market Share by Country in 2019
Figure 42. Europe Alpha Glucosidase Inhibitors Revenue Market Share by Country in 2019
Figure 43. Germany Alpha Glucosidase Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 44. Germany Alpha Glucosidase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Alpha Glucosidase Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 46. France Alpha Glucosidase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Alpha Glucosidase Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 48. U.K. Alpha Glucosidase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Alpha Glucosidase Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 50. Italy Alpha Glucosidase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Alpha Glucosidase Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 52. Russia Alpha Glucosidase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Alpha Glucosidase Inhibitors Market Share by Type in 2019
Figure 54. Europe Alpha Glucosidase Inhibitors Market Share by Application in 2019
Figure 55. Asia Pacific Alpha Glucosidase Inhibitors Sales Growth Rate 2015-2020 (g)
Figure 56. Asia Pacific Alpha Glucosidase Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Alpha Glucosidase Inhibitors Sales Market Share by Region in 2019
Figure 58. Asia Pacific Alpha Glucosidase Inhibitors Revenue Market Share by Region in 2019
Figure 59. China Alpha Glucosidase Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 60. China Alpha Glucosidase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Alpha Glucosidase Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 62. Japan Alpha Glucosidase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Alpha Glucosidase Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 64. South Korea Alpha Glucosidase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Alpha Glucosidase Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 66. India Alpha Glucosidase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Alpha Glucosidase Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 68. Australia Alpha Glucosidase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Alpha Glucosidase Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 70. Taiwan Alpha Glucosidase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Alpha Glucosidase Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 72. Indonesia Alpha Glucosidase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Alpha Glucosidase Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 74. Thailand Alpha Glucosidase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Alpha Glucosidase Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 76. Malaysia Alpha Glucosidase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Alpha Glucosidase Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 78. Philippines Alpha Glucosidase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Alpha Glucosidase Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 80. Vietnam Alpha Glucosidase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Alpha Glucosidase Inhibitors Market Share by Type in 2019
Figure 82. Asia Pacific Alpha Glucosidase Inhibitors Market Share by Application in 2019
Figure 83. Latin America Alpha Glucosidase Inhibitors Sales Growth Rate 2015-2020 (g)
Figure 84. Latin America Alpha Glucosidase Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Alpha Glucosidase Inhibitors Sales Market Share by Country in 2019
Figure 86. Latin America Alpha Glucosidase Inhibitors Revenue Market Share by Country in 2019
Figure 87. Mexico Alpha Glucosidase Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 88. Mexico Alpha Glucosidase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Alpha Glucosidase Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 90. Brazil Alpha Glucosidase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Alpha Glucosidase Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 92. Argentina Alpha Glucosidase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Alpha Glucosidase Inhibitors Market Share by Type in 2019
Figure 94. Latin America Alpha Glucosidase Inhibitors Market Share by Application in 2019
Figure 95. Middle East and Africa Alpha Glucosidase Inhibitors Sales Growth Rate 2015-2020 (g)
Figure 96. Middle East and Africa Alpha Glucosidase Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Alpha Glucosidase Inhibitors Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Alpha Glucosidase Inhibitors Revenue Market Share by Country in 2019
Figure 99. Turkey Alpha Glucosidase Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 100. Turkey Alpha Glucosidase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Alpha Glucosidase Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 102. Saudi Arabia Alpha Glucosidase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Alpha Glucosidase Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 104. U.A.E Alpha Glucosidase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Alpha Glucosidase Inhibitors Market Share by Type in 2019
Figure 106. Middle East and Africa Alpha Glucosidase Inhibitors Market Share by Application in 2019
Figure 107. North America Alpha Glucosidase Inhibitors Sales Growth Rate Forecast (2021-2026) (g)
Figure 108. North America Alpha Glucosidase Inhibitors Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Alpha Glucosidase Inhibitors Sales Growth Rate Forecast (2021-2026) (g)
Figure 110. Europe Alpha Glucosidase Inhibitors Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Alpha Glucosidase Inhibitors Sales Growth Rate Forecast (2021-2026) (g)
Figure 112. Asia Pacific Alpha Glucosidase Inhibitors Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Alpha Glucosidase Inhibitors Sales Growth Rate Forecast (2021-2026) (g)
Figure 114. Latin America Alpha Glucosidase Inhibitors Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Alpha Glucosidase Inhibitors Sales Growth Rate Forecast (2021-2026) (g)
Figure 116. Middle East and Africa Alpha Glucosidase Inhibitors Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
リソソームα-グルコシダーゼの世界市場（～2026年） Market Analysis and Insights: Global Lysosomal Alpha Glucosidase Market The global Lysosomal Alpha Glucosidase market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Lysosomal Alpha Glucosidase Scope and Market Size Lysosomal…- 腫瘍壊死因子α阻害剤の世界市場（～2026年） The tumor necrosis factor alpha (TNF-a) inhibitors represent one of the major treatment methods for inflammatory diseases. Globally, this drug class is known to be the most successful drugs in the overall pharmaceutical industry. Several conditions such as inflammations, rheumatoid arthritis (RA), i…
- DPP IV阻害剤（DPP-4阻害剤）の世界市場（～2026年） DPP IV inhibitors are a class of hypoglycemic agents that block the enzyme named dipeptidyl peptidase IV. Dipeptidyl peptidase IV enzyme break down the proteins that are responsible for stimulating the insulin producing cells that slows down gastric secretion. Proteins can activate the release of in…
- シグナル伝達阻害剤の世界市場（～2026年） Signal transduction inhibitors are drugs that may prevent the ability of cancer cells to multiply quickly and invade other tissues. Growing need for effective cancer diagnostics and innovative therapies for cancer treatment are expected to be the major factors driving the signal transduction inhibit…
- インターロイキン阻害剤の世界市場（～2026年） Interleukin (IL) are group of cytokines that are synthesized by lymphocytes, monocytes, macrophages, and other cells. They regulate cell growth, cell differentiation, and cell motility. Fifteen different types of interleukin are present in body. Interleukin inhibitors are immunosuppressive agents th…